Socio Today
The landscape of neonatal health in Indonesia faces a significant challenge as medical experts highlight the complexities surrounding Congenital Heart Disease (CHD), locally known as Penyakit Jantung Bawaan (PJB). While the precise etiology of many congenital heart defects remains a subject of ongoing medical research, health authorities are increasingly focusing on identifiable risk factors that can be mitigated during pregnancy. Dr. Rizky Adriansyah, MKed, a pediatric specialist and Chairman of the Cardiology Coordination Unit of the Indonesian Pediatric Association (IDAI), recently emphasized that while a direct cause-and-effect relationship is often difficult to establish, certain environmental and physiological factors during gestation play a pivotal role in the development of these conditions.
Speaking at a specialized webinar conducted on February 14, 2023, Dr. Rizky noted that at least three primary risk factors have dominated recent medical literature: maternal infections such as rubella, a deficiency in folic acid, and the consumption of specific medications—particularly anti-seizure drugs—during pregnancy. These factors are known to interfere with the delicate biological processes of fetal organogenesis, specifically during the first trimester when the heart’s structure is being formed. The urgency of this issue is underscored by national data from 2017, which identifies CHD as the second leading cause of neonatal mortality in Indonesia, accounting for approximately 17 percent of deaths in the newborn period, surpassed only by complications arising from prematurity.
The Critical Window of Fetal Development
The formation of the human heart is an intricate process that begins remarkably early in pregnancy. Between the third and eighth weeks of gestation, the heart evolves from a simple tube into a complex four-chambered organ. It is during this narrow window that the fetus is most vulnerable to external disruptions. Dr. Rizky explained that while the exact trigger for a defect might remain unknown in many cases, the presence of certain risk factors significantly elevates the probability of structural abnormalities.
Historically, lifestyle choices such as smoking and alcohol consumption by the mother were considered the primary drivers of CHD. However, contemporary clinical observations have complicated this narrative. Many infants are born with heart defects to mothers who maintained healthy lifestyles and avoided tobacco and alcohol. This reality has shifted the medical community’s focus toward broader physiological and environmental influences. The "three pillars" of risk—infection, nutrition, and medication—represent areas where proactive medical intervention and public health education can make a tangible difference in birth outcomes.
Rubella, or German measles, remains a particularly potent threat. When a pregnant woman contracts the virus, it can cross the placental barrier, leading to Congenital Rubella Syndrome (CRS), of which heart defects are a hallmark. Similarly, folic acid (Vitamin B9) is essential for DNA synthesis and repair. A deficiency in this nutrient is not only linked to neural tube defects but is also increasingly recognized as a factor in the malformation of the heart’s septa and valves. Furthermore, the use of certain pharmaceutical agents, such as valproate used in epilepsy treatment, has been documented to interfere with the signaling pathways required for proper cardiac development.
Statistical Burden and Global Context
The prevalence of Congenital Heart Disease in Indonesia mirrors global trends reported by the World Health Organization (WHO), yet the local capacity for intervention presents a stark contrast to developed nations. According to WHO data, approximately one in every 100 newborns worldwide is diagnosed with some form of CHD. Of these cases, an estimated 25 percent are classified as "critical" CHD, requiring surgical intervention or catheter-based procedures within the first year—and often the first month—of life. This translates to roughly two to four cases per 1,000 live births.
In the Indonesian context, the sheer volume of births—estimated at over 4.4 million per year—means that tens of thousands of children are born with heart defects annually. However, Dr. Rizky revealed a sobering statistic: less than 50 percent of these cases receive the necessary medical treatment in Indonesia. This gap in care is attributed to a multi-faceted crisis involving geographical access, a lack of diagnostic infrastructure, a shortage of specialized pediatric cardiologists and cardiovascular surgeons, and a general lack of public awareness regarding the symptoms of heart distress in infants.
The concentration of advanced cardiac centers in major urban hubs like Jakarta leaves families in remote provinces with few options. For a child born in a rural area of East Nusa Tenggara or Papua, the journey to a facility capable of performing neonatal heart surgery is often prohibitively expensive and logistically impossible, leading to high mortality rates for conditions that are technically treatable.
The Diagnostic Challenge: From Stethoscopes to Oximetry
Early detection is the most critical factor in improving the survival rates of infants with CHD. Dr. Rizky pointed out that many cases go undiagnosed because the symptoms can be subtle or attributed to other common neonatal issues. Clinical signs of CHD often include poor weight gain, difficulty feeding (the infant may tire easily or sweat during breastfeeding), and a bluish tint to the skin or lips (cyanosis). In critical cases, symptoms can manifest rapidly within the first 24 to 48 hours of life or during the first week.
To combat the delay in diagnosis, IDAI is advocating for the widespread adoption of simple, cost-effective screening methods. One of the most effective tools currently available is the pulse oximetry test. This non-invasive procedure involves placing a sensor on the baby’s right hand and either foot to measure oxygen saturation levels in the blood. Significant discrepancies between the two readings or low overall saturation can indicate a heart defect before the baby even shows physical signs of distress. Dr. Rizky described this method as sensitive, fast, and inexpensive, making it ideal for use in primary care settings across the archipelago.
Furthermore, the traditional use of the stethoscope remains a vital first line of defense. The detection of a heart murmur—an unusual sound heard between heartbeats—should immediately trigger a referral for more advanced diagnostic imaging, such as an echocardiography (an ultrasound of the heart). Despite the effectiveness of these tools, the "murmur" is often missed if the healthcare provider is not specifically trained to listen for the subtle nuances of neonatal heart sounds.
Strategies for Prevention and the Role of Primary Care
While CHD cannot always be prevented, the medical community emphasizes that the risk can be substantially reduced through comprehensive prenatal care. The primary recommendation for women of childbearing age is to ensure they are vaccinated against rubella before becoming pregnant. This single step can eliminate the risk of Congenital Rubella Syndrome. Additionally, the consistent intake of folic acid supplements and a nutrient-rich diet during the preconception period and throughout pregnancy is essential.
Dr. Rizky stressed that once a baby is born with a heart defect, the window for prevention has closed, and the focus must shift entirely to management and intervention. This places a heavy responsibility on frontline healthcare workers, particularly midwives (bidan), who attend the majority of births in Indonesia. IDAI has been active in promoting educational resources, including a YouTube channel titled "Sehatkan Jantung Anak Indonesia," which provides instructional content on how to perform cardiac screenings.
"Health workers, including midwives, can perform these checks in less than five minutes," Dr. Rizky noted. The goal is to empower local medical personnel to identify potential heart issues immediately after birth, ensuring that the critical 24-to-48-hour window is not missed. If regional authorities and parents can cooperate in these early detection efforts, the rate of successfully managed cases could rise significantly.
Broader Implications and the Path Forward
The failure to address CHD has profound socio-economic implications for Indonesia. Beyond the immediate tragedy of infant mortality, untreated heart disease leads to a lifetime of disability, reduced economic productivity, and an increased burden on the national healthcare system (BPJS Kesehatan). Children with uncorrected heart defects often suffer from chronic respiratory infections, developmental delays, and physical limitations that prevent them from attending school or eventually entering the workforce.
Addressing this issue requires a systemic overhaul of how pediatric cardiac care is delivered. This includes not only increasing the number of specialists but also decentralizing care. The government’s recent initiatives to upgrade regional hospitals are a step in the right direction, but they must be accompanied by rigorous training programs for general practitioners and nurses in neonatal cardiac care.
Furthermore, there is a pressing need for a national CHD registry. Currently, data collection is fragmented, making it difficult for policymakers to allocate resources effectively. A centralized database would allow the Ministry of Health to identify "hotspots" of CHD and investigate whether environmental factors, such as local pollution or specific nutritional deficiencies, are contributing to higher incidences in certain regions.
In conclusion, the fight against Congenital Heart Disease in Indonesia is a race against time and geography. While the medical causes of CHD remain complex and often mysterious, the path toward reducing its impact is clear: better maternal nutrition, universal vaccination, and a mandate for pulse oximetry screening for every newborn. As Dr. Rizky Adriansyah and the IDAI have highlighted, the tools to save these children already exist; the challenge lies in ensuring they are available to every child, regardless of where they are born in the country. The shift from late-stage crisis management to early detection and prevention is not just a medical necessity—it is a moral imperative for the nation’s future.
